Page results
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
Information about our UCLH Charity, charity funds and associated charities.
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
UCLH is the first NHS trust to pilot a personalised educational package for patients living with stroke.
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
-
Our staff have rated UCLH as the top trust in England, improving on our ranking from last year when we were third best in England and top in London.
-
UCLH will play a vital role in a new respiratory virus study.
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
File results
-
FOI/2023/0458 - Patient trolleys
-
FOI/2023/0459 - Multiple myeloma treatment
-
FOI/2023/0461 - UCLH operating system software/ data centres hybrid cloud
-
FOI/2023/0462 - Patients to hotels
-
FOI/2023/0463 - Extravasation injuries
-
FOI/2023/0466 - Language services (interpreting and translation services)
-
FOI/2023/0471 - Treatment of HIV & PrEP
-
FOI/2023/0473 - Treatment for myelofibrosis
-
FOI/2023/0474 - Number of live births, still births and neonatal deaths
-
FOI/2023/0475 - Agency usage for the decontamination department